Abstract
In contradistinction to the observation made before that iproniazid has a potentiating effect on certain amines in guinea pigs, human studies have shown that this effect has very little clinical importance, when both the amines and the amine oxidase inhibitor are given in the usual therapeutic doses. However, neither in man nor in the guinea pig pretreatment with iproniazid showed a potentiating effect on amines which are not substrates of monoamine oxidase (ephedrine and amphetamine). Patients with epilepsy and allergic disease may receive iproniazid.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BRODY M., GOETZ F. Studies on the gastrointestinal effects of marsilid. J Clin Exp Psychopathol. 1958 Apr-Jun;19(2 Suppl 1):146–151. [PubMed] [Google Scholar]
- REBHUN J., FEINBERG S. M., ZELLER E. A. Potentiating effect of iproniazid on action of some sympathicomimetic amines. Proc Soc Exp Biol Med. 1954 Oct;87(1):218–220. doi: 10.3181/00379727-87-21339. [DOI] [PubMed] [Google Scholar]
- REILLY R. H., KILLAM K. F., JENNEY E. H., MARSHALL W. H., TAUSIG T., APTER N. S., PFEIFFER C. C. Convulsant effects of isoniazid. J Am Med Assoc. 1953 Aug 1;152(14):1317–1321. doi: 10.1001/jama.1953.03690140025006. [DOI] [PubMed] [Google Scholar]
- UDENFRIEND S., WEISSBACH H., BOGDANSKI D. F. Effect of iproniazid on serotonin metabolism in vivo. J Pharmacol Exp Ther. 1957 Jun;120(2):255–260. [PubMed] [Google Scholar]